
1.75BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US81734D1046
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
8.43
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.8
Wall Street Target Price
45.00
EPS Estimate Current Year
-1.73
EPS Estimate Next Year
-2.66
EPS Estimate Current Quarter
-0.2744
EPS Estimate Next Quarter
-0.1731
Most Recent Quarter
-
Revenue TTM
72,255,000
Gross Profit TTM
72,255,000
EBITDA
-66,559,000
Profit Margin
-49.88%
Return On Assets TTM
-8.49%
Return On Equity TTM
-9.26%
Revenue Per Share TTM
1.625
Qtly Revenue Growth YOY
12011.00%
Diluted Eps TTM
-0.8
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
107
Price Sales TTM
24.2362
Price Book MRQ
4.6248
Enterprise Value Revenue
19
Enterprise Value EBITDA
0
523.91
5.61%359.00
3.08%808.05
3.02%93.67
2.24%57.97
2.11%206.97
0.89%23.72
0.85%129.82
0.50%866.11
0.12%266.09
-1.21%